Bridging the immunogenicity of a tetravalent dengue vaccine (TAK-003) from children and adolescents to adults

Abstract Immunobridging is an important methodology that can be used to extrapolate vaccine efficacy estimates to populations not evaluated in clinical studies, and that has been successfully used in developing many vaccines. Dengue, caused by a mosquito-transmitted flavivirus endemic to many tropic...

Full description

Bibliographic Details

Published in:	npj Vaccines
Main Authors:	Inge LeFevre, Lulu Bravo, Nicolas Folschweiller, Eduardo Lopez Medina, Edson Duarte Moreira, Francesco Nordio, Mayuri Sharma, Leslie M. Tharenos, Vianney Tricou, Veerachai Watanaveeradej, Peter J. Winkle, Shibadas Biswal
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-05-01
Online Access:	https://doi.org/10.1038/s41541-023-00670-6